Data Year:

For its 2025 fiscal year, PENUMBRA INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Adam Elsesser
Chief Executive Officer and former President
Total Compensation $851,620 View details Pay Rank By Title In MFG Durable industry #734 View more
Maggie Yuen
Chief Financial Officer
Total Compensation $2,427,993 View details Pay Rank By Title In MFG Durable industry #318 View more
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Total Compensation $2,427,897 View details Pay Rank By Title In MFG Durable industry #65 View more
Lambert Shiu
Chief Accounting Officer
Total Compensation $2,179,577 View details Pay Rank By Title In MFG Durable industry #17 View more
Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
Total Compensation $6,374,224 View details Pay Rank By Title In MFG Durable industry #35 View more
Daniel J. Brennan
Former Executive Vice President and Chief Financial Officer
Total Compensation $6,192,966 View details Pay Rank By Title In MFG Durable industry #77 View more
Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
Total Compensation $4,099,961 View details Pay Rank By Title In MFG Durable industry #69 View more
Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiovascular
Total Compensation $7,893,007 View details Pay Rank By Title In MFG Durable industry #23 View more
Jonathan R. Monson
Executive Vice President and Chief Financial Officer
Total Compensation $4,265,703 View details Pay Rank By Title In MFG Durable industry #153 View more
Vance R. Brown
Senior Vice President, General Counsel and Corporate Secretary
Total Compensation $3,800,719 View details Pay Rank By Title In MFG Durable industry #22 View more
Michael F. Mahoney
Chairman of the Boston Scientific Board, President and Chief Executive Officer
Total Compensation $23,090,439 View details Pay Rank By Title In MFG Durable industry #39 View more
Shruthi Narayan
President
Total Compensation $4,376,926 View details Pay Rank By Title In MFG Durable industry #39 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at PENUMBRA INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. PENUMBRA INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. PENUMBRA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Adam Elsesser
Chief Executive Officer and former President
Total Cash $850,000 Equity $0 Other $1,620 $851,620
Maggie Yuen
Chief Financial Officer
Total Cash $715,385 Equity $1,705,526 Other $7,082 $2,427,993
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Total Cash $715,385 Equity $1,705,526 Other $6,986 $2,427,897
Lambert Shiu
Chief Accounting Officer
Total Cash $594,231 Equity $1,578,436 Other $6,910 $2,179,577
Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
Total Cash $1,757,323 Equity $4,397,234 Other $219,667 $6,374,224
Daniel J. Brennan
Former Executive Vice President and Chief Financial Officer
Total Cash $1,758,994 Equity $4,397,234 Other $36,738 $6,192,966
Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
Total Cash $1,495,168 Equity $2,545,555 Other $59,238 $4,099,961
Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiovascular
Total Cash $2,350,605 Equity $5,496,745 Other $45,657 $7,893,007
Jonathan R. Monson
Executive Vice President and Chief Financial Officer
Total Cash $1,431,848 Equity $2,795,402 Other $38,453 $4,265,703
Vance R. Brown
Senior Vice President, General Counsel and Corporate Secretary
Total Cash $1,556,837 Equity $2,198,596 Other $45,286 $3,800,719
Michael F. Mahoney
Chairman of the Boston Scientific Board, President and Chief Executive Officer
Total Cash $5,444,604 Equity $17,358,036 Other $287,799 $23,090,439
Shruthi Narayan
President
Total Cash $730,769 Equity $3,639,575 Other $6,582 $4,376,926
For its 2025 fiscal year, PENUMBRA INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Adam Elsesser CEO Pay $851,621 Median Employee Pay $74,923 CEO Pay Ratio 11:1
For its 2025 fiscal year, PENUMBRA INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Arani Bose, M.D. Total Cash $259,890
Bridget O'Rourke Total Cash $289,890
Harpreet Grewal Total Cash $267,390
Janet Leeds Total Cash $282,390
Surbhi Sarna Total Cash $274,890
Thomas Wilder Total Cash $288,140
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.